Bromocriptine is available in two forms: an oral tablet/capsule (2.5 to 5.0 mg) for the treatment of hyperprolactinemia, acromegaly, and Parkinson disease, and another oral tablet/capsule (0.8 mg) for the treatment of type 2 diabetes mellitus.

- Hyperprolactinemia: Initial dose of 1.25 to 2.50 mg/day, followed by an increase over the following days with a final maintenance dose of about 5 mg/day.

- Acromegaly: Initial dose of 1.25 to 2.50 mg/day and an increase in 2.50 mg increments until desired GH blood concentrations are reached, with maintenance doses ranging from 7.50 to 30.0 mg/day.

- Parkinson Disease: Initial dose of 2.50 mg/day with an increase in increments of 2.50 mg based on tolerance and effect. Use the lowest dose possible to achieve symptomatic control, with a low dose considered less than 30.0 mg/day and a high dose considered 31.0 to 100 mg/day.

- Type 2 Diabetes Mellitus: Initial dose of 0.8 mg/day with a weekly increase of 0.8 mg until the desired glycemic control is reached, with a maximum dose of 4.80 mg/day.